Schiff bases of 3-[(4-amino-5-thioxo-1,2,4-triazole-3-yl) methyl]-2(3H)-benzoxazolone derivatives: Synthesis and biological activity

Revue Roumaine de Chimie

Volumn 57, Issue 3, 2012, Pages 187-195

  Urlu Cicekli, Solen ^a   Onkol, Tijen ^a   Ozgen, Selda ^a   Sahin, M Fethi ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870821761     PISSN: 00353930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Z.A. Kaplancikli, G. Turan-Zitouni, A.Ozdemir and G. Revial, Eur. J. Med. Chem., 2008, 43, 155-159.
2. H. Bayrak, A. Demirbas, N. Demirbas and S.A. Karaoglu, Eur. J. Med. Chem., 2009, 44, 4362-4366.
3. G.V.S. Kumar, Y. Rajendraprasad, B.P. Mallikarjuna, S. M. Chandrashekar and C. Kistayya, Eur. J. Med. Chem., 2010, 45, 2063-2074.
4. M.F.E. Shehry, A.A. Abu-Hashem and E.M.E Telbani, Eur. J. Med. Chem., 2010, 45, 1906-1911.
5. S. P. Aytaç, B.Tozkoparan, F. B.Kaynak, G. Aktay, O. Goktas and S. Unuvar, Eur. J. Med. Chem., 2009, 44, 4528-4538.
6. P.Valentina, K. Ilango, M.Deepthi, P. Harusha, G. Pavani, K. L. Sindhura and C.H.G. Keerthanan, J. Pharm. Sci. Res., 2009, 1, 74-77.
7. G.Q. Hu, L.L.Hou, S.Q. Xie and W. L. Huang, Chinese J. Chem., 2008, 26, 1145-1149.
8. B. R. Abdel-Wahab, H. A. Abdel-Aziz and E. M. Ahmed, Monatsh Chem., 2009, 140, 601-605.
9. B. P. Mallikarjuna, B.S. Sastry, G.V.S.Kumar, Y. Rajendraprasad, S.M. Chandrashekar and K. Sathisha, Eur. J. Med. Chem., 2009, 44, 4739-4746.
10. S. Balram, M. S. Ranawat, R. Sharma, A. Bhandari and S. Sharma, Eur. J. Med. Chem., 2010, 45, 2938-2942.
11. M. Shiradkar, G.V. S.Kumar, V. Dasari, S. Tatikonda, K. C. Akula and R. Shah, Eur. J. Med. Chem., 2007, 42, 807-816.
12. A. K. Man and R. Shahidan, J. Macromolecular Sci., Part A: Pure and Applied Chemistry, 2007, 44, 651-657.
13. C. O. Kappe, Angew. Chem. Int. Ed., 2004, 43, 6250-6284.
14. S. Cankara, "Studies on the synthesis and cox inhibitory activities of some 6-(thiazole-4-yl)-2-oxo-3H-benzoxazole derivatives", MsD Thesis, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkey, 2007.
15. G. Eren, S. Ünlü, M.T. Nuñez, L. Labeaga, F. Ledo, A. Entrena, E. Banoǧlu, G. Costantino and M. F. Şahin, Bioorg. Med. Chem., 2010, 18, 6367-6376.
16. T. Onkol, Y. Dundar, B.Sirmagul, K. Erol and M.F. Sahin, J. Fac. Pharm. Gazi, 2002, 19, 15-24.
17. X. H. Sun, Y. Tao, Y. F. Liu and B.Chen, Chinese J. Chem., 2007, 25, 1573-1576.
18. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS), "Performance Standards for Antimicrobial Disk Susceptibility Tests Approved Standard, M2-A9", Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA, 2006.
19. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS), "Performance Standards for Antimicrobial Susceptibility Testing 18th Informational Supplement. CLSI M100-S18", Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA, 2008.
20. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS): "Reference method for broth dilution antifungal susceptibility testing yeast; approved standard, M27-A3", Clinical and Laboratory Standarts Institute, 940 West Valley Road, Wayne, Pennsylvania, USA, 2008.
21. S.G.F. Franzblau, R.S. Witzig, J.C. Mclaughlin, P. Torres P., G.Madico, A. Hernandez, M.T. Degnan, M. B. Cook, V.K. Quenzer, R. M. Ferguson and R. H. Gilman, J. Clin. Microbiol., 1998, 362-366.